
Galapagos NV GLPG
Quartalsbericht 2025-Q4
hinzugefügt 06.05.2026
Galapagos NV DSO 2011-2026 | GLPG
DSO Jährlich Galapagos NV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 56.5 | 148 | 72.6 | 84.8 | 89 | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 148 | 56.5 | 90.2 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
2.94 K | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
29 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
559 | $ 1.73 | 5.18 % | $ 203 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Celldex Therapeutics
CLDX
|
321 | $ 31.65 | 2.59 % | $ 2.1 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 53.52 | 3.74 % | $ 4.81 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Compugen Ltd.
CGEN
|
400 | $ 2.68 | 1.13 % | $ 250 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
39.1 | $ 31.66 | 1.18 % | $ 852 M | ||
|
Affimed N.V.
AFMD
|
31.4 | - | -34.95 % | $ 21.5 M | ||
|
Celyad Oncology SA
CYAD
|
64.4 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | ||
|
IMV
IMV
|
2.16 K | - | - | $ 13.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Hutchison China MediTech Limited
HCM
|
93.9 | $ 11.72 | -0.26 % | $ 10.1 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
3.66 K | - | -4.36 % | $ 27 M | ||
|
Heron Therapeutics
HRTX
|
198 | $ 0.9 | 2.13 % | $ 150 M | ||
|
Anika Therapeutics
ANIK
|
76.5 | $ 14.76 | -0.87 % | $ 212 M | ||
|
Advaxis
ADXS
|
3.28 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
126 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.35 | -4.83 % | $ 5.51 M |